Literature DB >> 21868036

Lower airway nitric oxide is increased in children with sickle cell disease.

Dhenuka K Radhakrishnan1, Glenda N Bendiak, Dimas Mateos-Corral, Suhail Al-Saleh, Rakesh Bhattacharjee, Melanie Kirby-Allen, Hartmut Grasemann.   

Abstract

OBJECTIVES: To determine alveolar and airways nitric oxide (NO) levels in children with sickle cell disease (SCD). STUDY
DESIGN: Multiple flows fractional exhaled NO (FE(NO)), bronchial NO flux (J'aw(NO)), and alveolar NO concentration (Ca(NO)) were determined prospectively in 16 non-atopic children with SCD in a tertiary ambulatory clinic and compared with those in 10 children with primary ciliary dyskinesia and 22 healthy control subjects. Differences in FE(NO), J'aw(NO), and Ca(NO) were compared with mixed model analysis and Mann-Whitney tests.
RESULTS: Children with SCD had reference range FE(NO) at 50 mL/sec, but FE(NO) was elevated across all flows compared with healthy control subjects (mean difference=2.10±0.91 parts per billion, P=.03). Subjects with SCD had increased J'aw(NO) (1177±533 picoliters per second versus 833±343 picolitres per second, P=.03), and Ca(NO) was no different from control subjects. In contrast, children with primary ciliary dyskinesia had decreased FE(NO) (mean difference=3.36±1.24 parts per billion, P<.01) and J'aw(NO) (507±259 picoliters per second versus 833±343 picoliters per second, P<.01).
CONCLUSIONS: Lower airways NO is increased in children with SCD. Elevation of J'aw(NO) may represent dysregulation of NO metabolism or subclinical airways inflammation.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868036     DOI: 10.1016/j.jpeds.2011.06.048

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma.

Authors:  Devika R Rao; Wanda Phipatanakul
Journal:  Expert Rev Clin Immunol       Date:  2016-02-19       Impact factor: 4.473

2.  Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.

Authors:  Emmanuil S Hatzipantelis; Zoe Dorothea Pana; N Gombakis; A Taparkou; V Tzimouli; D Kleta; D J Zafeiriou; V Garipidou; F Kanakoudi; M Athanassiou
Journal:  Int J Hematol       Date:  2013-06-27       Impact factor: 2.490

3.  Exhaled nitric oxide: Not associated with asthma, symptoms, or spirometry in children with sickle cell anemia.

Authors:  Robyn T Cohen; Mark Rodeghier; Fenella J Kirkham; Carol L Rosen; Jane Kirkby; Michael R DeBaun; Robert C Strunk
Journal:  J Allergy Clin Immunol       Date:  2016-08-09       Impact factor: 10.793

4.  Oxidative Stress and Therapeutic Development in Lung Diseases.

Authors:  Leah Villegas; Timothy Stidham; Eva Nozik-Grayck
Journal:  J Pulm Respir Med       Date:  2014-07-15

5.  Airway and alveolar nitric oxide production, lung function, and pulmonary blood flow in sickle cell disease.

Authors:  Alan Lunt; Na'eem Ahmed; Gerrard F Rafferty; Moira Dick; David Rees; Sue Height; Swee Lay Thein; Anne Greenough
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

Review 6.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

7.  The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditions.

Authors:  Marcel H Fens; Sandra K Larkin; Bryan Oronsky; Jan Scicinski; Claudia R Morris; Frans A Kuypers
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

Review 8.  Sickle cell disease: wheeze or asthma?

Authors:  Robyn T Cohen; Elizabeth S Klings; Robert C Strunk
Journal:  Asthma Res Pract       Date:  2015-12-08

9.  Ocular manifestations of sickle cell disease and genetic susceptibility for refractive errors.

Authors:  Palak Shukla; Henu Verma; Santosh Patel; P K Patra; L V K S Bhaskar
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.